Serum uric acid and related factors in 500 hospitalized subjects

Metabolism: Clinical and Experimental

Volumn 45, Issue 12, 1996, Pages 1557-1561

  Saggiani, Francesca ^b   Pilati, Stefano ^b   Targher, Giovanni ^b   Branzi, Paola ^b   Muggeo, Michele ^b   Bonora, Enzo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIURETIC AGENT; GLUCOSE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PREVALENCE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0030474867     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90188-2     Document Type: Article

References (41)

1. Mikkelsen WM, Dodge HJ, Valkenburg H: The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Tecumseh, Michigan 1959-1960. Am J Med 39:242-251, 1965
2. Hall AP, Barry PE, Dawber TR, et al: Epidemiology of gout and hyperuricemia. A long term population study. Am J Med 42:27-37, 1967
3. Zalokar J, Lellouch J, Claude JR, et al: Serum uric acid in 23,923 men and gout in a subsample of 4,257 men in France. J Chronic Dis 25:305-312, 1972
4. Klein R, Klein BE, Cornoni JC, et al: Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease. Evans County, Georgia. Arch Intern Med 132:401-410, 1973
5. Persky VW, Dyer AR, Idris-Soven E, et al: Uric acid: A risk factor for coronary heart disease? Circulation 59:969-977, 1979
6. Freedman DS, Williamson DF, Gunter EW, et al: Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 141:637-644, 1995
7. Paulus HE, Coutts A, Calabro JJ, et al: Clinical significance of hyperuricemia in routinely screened hospitalized men. JAMA 211:277-281, 1970
8. Kelley WN, Fox IH, Palella TD: Gout and related disorders of purine metabolism, in Kelley WN, Harris ED, Ruddy S, et al (eds): Text Book of Rheumatology. Philadelphia, PA, Saunders, 1989, pp 1395-1448
9. Brand FN, McGee DL, Kannel WB, et al: Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 121:11-18, 1985
10. Zalokar J, Lellouch J, Claude JR, et al: Epidemiology of serum uric acid and gout in Frenchmen. J Chronic Dis 27:59-75, 1974.
11. Whitehouse FW, Cleary WJ: Diabetes mellitus in patients with gout. JAMA 197:113-116, 1966
12. Goldbourt U, Medalie JH, Herman JB, et al: Serum uric acid: Correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis 33:435-443, 1980
13. Reaven GM: Banting Lecture: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
14. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
15. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
16. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
17. Modan M, Halkin H, Karasik A, et al: Elevated serum uric acid - A facet of hyperinsulinaemia. Diabetologia 30:713-718, 1987
18. Zavaroni I, Mazza S, Fantuzzi M, et al: Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 234:25-30, 1993
19. Cigolini M, Targher G, Tonoli M, et al: Hyperuricaemia: Relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes 19:92-96, 1995
20. Facchini F, Chen YDI, Hollenbeck CB, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 266:3008-3011, 1991
21. Vuorinen-Markkola H, Yki-Jarvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29, 1994
22. Quinones Galvan A, Natali A, Baldi S, et al: Effect of insulin on uric acid excretion in humans. Am J Physiol 268:E1-E5, 1995
23. Kageyama N: A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system. Clin Chim Acta 31:421-426, 1971
24. Siedel J, Hagele EO, Ziegenhorn J, et al: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
25. Wahlefeld AW: Triglycerides: Determination after enzymatic hydrolysis, in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, NY, Academic, 1974, pp 1831-1836
26. Kadish AH, Little RL, Sternberg JC: A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
27. Bonsens BW, Taussky HH: On colorimetric determination of creatinine by Jaffé reaction. J Biol Chem 158:581-591, 1945
28. Rodger RSC, Laker MF, Flecther K, et al: Factors influencing normal reference intervals for creatinine, urea, and electrolytes in plasma, as measured with a Beckman Astra 8 Analyzer. Clin Chem 31:292-295, 1985
29. Bray GA: An approach to the classification and evaluation of obesity, in Björntorp P, Brodoff BN (eds): Obesity. Philadelphia, PA, Lippincott, 1992, pp 294-308
30. Consensus Conference: Treatment of hypertriglyceridemia. JAMA 251:1196-1201, 1984
31. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP). JAMA 269:3015-3023, 1993
32. World Health Organization: Diabetes mellitus: Report of a WHO study group. WHO Tech Rep Ser 727:1985
33. Subcommittee of WHO/ISH Mild Hypertension Liaison Committee: Summary of 1993 World Health Organisation International Society Hypertension guidelines for the management of mild hypertension. Br Med J 307:1541-1546, 1993
34. Dennis VW: Investigation of renal function, in Wyngaarden JB, Smith LH, Bennet JC (eds): Cecil Textbook of Medicine (ed 19). Philadelphia, PA, Saunders, 1988, p 494
35. Nicholls A, Snaith ML, Scott JT: Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1:449-451, 1973
36. Marinello E, Giuseppe RS, Marcolongo R: Plasma follicle-stimulating hormone, luteinizing hormone, and sex hormones in patients with gout. Arthritis Rheum 28:127-131, 1985
37. Greenblatt RB, Oettinger M, Bohler CSS: Estrogen-androgen levels in aging men and women: Therapeutic considerations. J Am Geriatr Soc 24:173-178, 1976
38. Berkowitz D: Gout, hyperlipidemia and diabetes interrelationships. JAMA 197:117-120, 1966
39. Herman JB, Goldbourt U: Uric acid and diabetes: Observation in a population study. Lancet 2:240-243, 1982
40. Boss GR, Seegmiller JE: Hyperuricemia and gout. Classification, complications and management. N Engl J Med 300:1459-1468, 1979
41. Messerli FH, Frohlich ED, Dreslinski GR, et al: Serum uric acid in essential hypertension: An indicator of renal involvement. Ann Intern Med 93:817-821, 1980